Angiotensin receptor blockers: new considerations in their mechanism of action (Q36474742)

14 August 2017

1 reference

title

Angiotensin receptor blockers: new considerations in their mechanism of action (English)

1 reference

14 August 2017

Domenic A Sica

1

1 reference

14 August 2017

1 May 2006

1 reference

Journal of Clinical Hypertension

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

5

1 reference

14 August 2017

381-385

1 reference

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Angiotensin AT2 receptors: cardiovascular hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Clinical pharmacokinetics of losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Clinical pharmacokinetics of candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Practical considerations of the pharmacology of angiotensin receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Treatment of non-dipper hypertension with bedtime administration of valsartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05141.X

10.1111/J.1524-6175.2005.05141.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16687949